Interferon Gamma and Tumor Necrosis Factor Alpha Are Inflammatory Biomarkers for Major Adverse Cardiovascular Events in Patients with Peripheral Artery Disease

Interferon Gamma and Tumor Necrosis Factor Alpha Are Inflammatory Biomarkers for Major Adverse Cardiovascular Events in Patients with Peripheral Artery Disease

<b>Background/Objectives:</b> Major adverse cardiovascular events (MACE)—including heart attacks and strokes—are the leading cause of death in patients with peripheral artery disease (PAD), yet biomarker research for MACE prediction in PAD patients remains limited. Inflammatory proteins...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ben Li, Eva Lindner, Raghad Abuhalimeh, Farah Shaikh, Houssam Younes, Batool Abuhalimeh, Abdelrahman Zamzam, Rawand Abdin, Mohammad Qadura
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Biomedicines
Subjects:	inflammatory proteins tumor necrosis factor alpha interferon gamma major adverse cardiovascular events prognosis peripheral artery disease
Online Access:	https://www.mdpi.com/2227-9059/13/7/1586
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prediction of Major Adverse Cardiovascular Events in Patients with Peripheral Artery Disease Using Circulating Immunomodulatory Proteins
by: Ben Li, et al.
Published: (2024-12-01)

Matrix Metalloproteinases 7 and 10 Are Prognostic Biomarkers for Systemic Cardiovascular Risk in Individuals with Peripheral Artery Disease
by: Ben Li, et al.
Published: (2025-06-01)

The Prognostic Potential of Insulin-like Growth Factor-Binding Protein 1 for Cardiovascular Complications in Peripheral Artery Disease
by: Ben Li, et al.
Published: (2025-07-01)

Growth Differentiation Factor 15 Predicts Cardiovascular Events in Peripheral Artery Disease
by: Ben Li, et al.
Published: (2025-07-01)

Interferon Status and Choice of Interferons Inducers in Frequently Ill Children
by: M. S. Savenkovа, et al.
Published: (2016-06-01)

Interferons alpha and gamma, pidotimod, and tilorone in the treatment of acute respiratory infections in patients with allergic rhinitis: a prospective, cohort clinical and immunological study
by: O. V. Kalyuzhin, et al.
Published: (2022-07-01)

Genetic Polymorphism of Interferon-Gamma +874T/A as a Risk Factor for Pulmonary Tuberculosis in Cirebon, Indonesia
by: Allain Umadela Deuxawalu Kiteswara, et al.
Published: (2024-11-01)

Immunoexpression of interferon-gamma in the interdental gingiva of chronic periodontitis patients with interferon-gamma (+874A/T) rs62559044 polymorphism
by: Nadia Sheibak, et al.
Published: (2022-09-01)

Relationship between Serum Interferon Gamma Level with Sputum Positivity of Acid-Fast Bacillus in New Case Pulmonary Tuberculosis
by: Andi Khomeini Takdir, et al.
Published: (2018-06-01)

Interferon alpha-induced reduction in the values of myeloid-derived suppressor cells in melanoma patients
by: Stanojević Ivan, et al.
Published: (2015-01-01)

DNA Methylation Patterns of Interferon Gamma Gene Promoter and Serum Level in Pulmonary Tuberculosis: Their Role in Prognosis
by: Zayr et al.
Published: (2019-03-01)

Successful treatment of hairy cell leukaemia with pegylated interferon-alpha-2A
by: Kata Ferenczi, et al.
Published: (2025-05-01)

Quantitative levels of interferon gamma as a biomarker in the aqueous and serum samples of infectious and noninfectious uveitis patients
by: Sahar Saad Eldeen Mohamed Shaban, et al.
Published: (2025-02-01)

Evaluation of the effectiveness and safety of interferon alpha-2b ointment and gel for prevention of acute respiratory infections in organized groups
by: K. V. Kozlov, et al.
Published: (2024-04-01)

DEVELOPMENT AND VALIDATION OF IMMUNOASSAY FOR IMMUNOGENICITY OF INTERFERON-ALPHA 2A DRUGS
by: E. V. Mityushova, et al.
Published: (2019-01-01)

A Comparative study between the two interferon gamma releasing assays in the diagnosis of pulmonary tuberculosis
by: Asmaa Z. Al- Ghreer, et al.
Published: (2023-02-01)

Antitumor effect of recombinant interferon-gamma in an experimental model of Ehrlich’s bilateral solid carcinoma
by: V. G. Isaeva, et al.
Published: (2022-06-01)

Studying the Effect of Tumor Necrosis Factor-Alpha and Tumor Necrosis Factor Gene Polymorphisms on the Incidence of Tuberculosis
by: Jalaledin Ghanavi, et al.
Published: (2025-04-01)

TYROSINE KINASE INHIBITORS AND INTERFERON
by: Maria Dimou, et al.
Published: (2014-01-01)

Telluride quantum dot-amplified immunosensor for interferon gamma – A TB antigen test biomarker
by: Sixolile Mini, et al.
Published: (2025-06-01)

Evaluation of the Performance of Widal Slide Agglutination Test Compared to Blood Culture and Evaluation of Interferon Gamma Response in the Diagnosis of Typhoid Fever
by: Mujahid, N.S., et al.
Published: (2020-12-01)

Tumor Necrosis Factor-Alpha’s Role in the Pathophysiology of Colon Cancer
by: Saleha Khan, et al.
Published: (2025-06-01)

Aspects of a Methodological Approach to Determination of Interferon Alpha Specific Activity
by: M. L. Baykova, et al.
Published: (2020-03-01)

Effect of chitosan nanogels loaded with vancomycin and gamma interferon on TNF-α gene expression in macrophage cell line activated with methicillin-resistant Staphylococcus aureus (MRSA)
by: Sahar Arkiya, et al.
Published: (2024-10-01)

Identification of hub six interferon alpha response genes and immune cell infiltration characteristics in low-grade glioma
by: Xue Zhang, et al.
Published: (2025-07-01)

Chronic hepatitis b with type I diabetes mellitus and autoimmune thyroiditis development during interferon alpha therapy
by: Sukran Kose, et al.
Published: (2011-07-01)

Effects of Treatment with Temsirolimus versus Interferon Alpha on Survival of Patients with Metastatic Renal Cell Carcinoma – Single-Center Real-World Experience
by: Ivan Levakov, et al.
Published: (2024-01-01)

Increased concentration of tumour necrosis factor alpha in the plasma of glaucoma patients
by: Trenkić Marija, et al.
Published: (2024-01-01)

Induction of Type 1, 2 and 3 Interferons by Acridone Acetates
by: S. S. Grigoryan, et al.
Published: (2020-05-01)

High Sensitivity L‐Cysteine Indium Telluriselenide Quantum Dot‐Inspired Aptasensor for Interferon Gamma TB Biomarker
by: Kaylin Cleo Januarie, et al.
Published: (2025-07-01)

Selective Glycopolymer Inhibitors of Galectin-3: Supportive Anti-Cancer Agents Protecting Monocytes and Preserving Interferon-Gamma Function
by: Filipová M, et al.
Published: (2025-05-01)

Evaluation of Diagnostic Performance of Three Commercial Interferon-Gamma Release Assays for <i>Mycobacterium tuberculosis</i>
by: Richard Kutame, et al.
Published: (2024-09-01)

Strategy of the Host-Directed Therapy for Tuberculosis: the Importance of Interferon-Gamma in the Pathogenesis and Therapy of Tuberculosis Infection
by: G. N. Mozhokina, et al.
Published: (2024-03-01)

PROGNOSTIC VALUE OF TUMOR NECROSIS FACTOR-ALPHA IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
by: E. N. Zotina, et al.
Published: (2016-08-01)

NOTCH and Tumor Necrosis Factor-Alpha Converting Enzyme Levels Could be used in COVID-19 for Risk Stratification
by: Dilay Karabulut, et al.
Published: (2022-10-01)

Investigation of Deficits in Auditory Emotional Content Recognition by Adult Cochlear Implant Users through the Study of Electroencephalographic Gamma and Alpha Asymmetry and Alexithymia Assessment
by: Giulia Cartocci, et al.
Published: (2024-09-01)

Interferon alpha-2b addition to intravitreal bevacizumab for diabetic macular edema: a randomized controlled trial
by: Saeed Karimi, et al.
Published: (2025-04-01)

The reduction of CSF tumor necrosis factor alpha levels in schizophrenia: no correlations with psychopathology and coincident metabolic characteristics
by: Zhu H, et al.
Published: (2016-11-01)

Levocarnitine inhibits tumor necrosis factor alpha-induced vascular cell adhesion molecule 1 expression
by: Hideo Misawa, et al.
Published: (2025-06-01)

The established of a machine learning model for predicting the efficacy of adjuvant interferon alpha1b in patients with advanced melanoma
by: Linhan Jiang, et al.
Published: (2024-11-01)